Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L BURNS

Showing results (161-170 of 1,148) with videos related to

Pageof 115
Sort By:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|August 7, 2001
HIV/AIDS: twenty years later and the battle still ragesF Romanelli, A L Burns, M H Mayer
Pediatric Cardiology|September 13, 2011
Early outcomes and prognostic factors for left atrioventricular valve reoperation after primary atrioventricular septal defect repairSonali S Patel, Trudy L Burns, Lazaros Kochilas
Progress in Clinical and Biological Research|January 1, 1990
Synexin, a new member of the annexin gene family, is a calcium channel and membrane fusion proteinH B Pollard, A L Burns, E Rojas
Journal of Biomechanics|January 1, 1984
Analysis of compressive creep behavior of the vertebral unit subjected to a uniform axial loading using exact parametric solution equations of Kelvin-solid models--Part I. Human intervertebral jointsM L Burns, I Kaleps, L E Kazarian
Antimicrobial Agents and Chemotherapy|April 21, 2010
Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patientsDanielle Elliott, Jane L Burns, Lucas R Hoffman
Drug and Alcohol Review|January 1, 1995
Policing pubs: what happens to crime?L Burns, B Flaherty, S Ireland, et al.
Cardiovascular Therapeutics|December 21, 2013
An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterolHua Ling, Tammy L Burns, Daniel E Hilleman
Clinical and Vaccine Immunology : CVI|February 26, 2016
Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective AntigenAnita Verma, Miriam M Ngundi, Drusilla L Burns
Current Opinion in Anaesthesiology|July 5, 2022
Perioperative and Periprocedural anesthetic management of opioid tolerant patients and patients with active and medically treated opioid use disorderStacey L Burns, Petra Majdak, Richard D Urman
Perspectives (Gerontological Nursing Association (Canada))|January 1, 1986
Career selection: planting the seed for gerontological nursingL Burns, F MacLeod, M MacTavish, et al.
Pageof 115

Showing results (161-170 of 1,148) with videos related to

Sort By:
Pageof 115
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|August 7, 2001
HIV/AIDS: twenty years later and the battle still ragesF Romanelli, A L Burns, M H Mayer
Pediatric Cardiology|September 13, 2011
Early outcomes and prognostic factors for left atrioventricular valve reoperation after primary atrioventricular septal defect repairSonali S Patel, Trudy L Burns, Lazaros Kochilas
Progress in Clinical and Biological Research|January 1, 1990
Synexin, a new member of the annexin gene family, is a calcium channel and membrane fusion proteinH B Pollard, A L Burns, E Rojas
Journal of Biomechanics|January 1, 1984
Analysis of compressive creep behavior of the vertebral unit subjected to a uniform axial loading using exact parametric solution equations of Kelvin-solid models--Part I. Human intervertebral jointsM L Burns, I Kaleps, L E Kazarian
Antimicrobial Agents and Chemotherapy|April 21, 2010
Exploratory study of the prevalence and clinical significance of tobramycin-mediated biofilm induction in Pseudomonas aeruginosa isolates from cystic fibrosis patientsDanielle Elliott, Jane L Burns, Lucas R Hoffman
Drug and Alcohol Review|January 1, 1995
Policing pubs: what happens to crime?L Burns, B Flaherty, S Ireland, et al.
Cardiovascular Therapeutics|December 21, 2013
An update on the clinical development of proprotein convertase subtilisin kexin 9 inhibitors, novel therapeutic agents for lowering low-density lipoprotein cholesterolHua Ling, Tammy L Burns, Daniel E Hilleman
Clinical and Vaccine Immunology : CVI|February 26, 2016
Mechanistic Analysis of the Effect of Deamidation on the Immunogenicity of Anthrax Protective AntigenAnita Verma, Miriam M Ngundi, Drusilla L Burns
Current Opinion in Anaesthesiology|July 5, 2022
Perioperative and Periprocedural anesthetic management of opioid tolerant patients and patients with active and medically treated opioid use disorderStacey L Burns, Petra Majdak, Richard D Urman
Perspectives (Gerontological Nursing Association (Canada))|January 1, 1986
Career selection: planting the seed for gerontological nursingL Burns, F MacLeod, M MacTavish, et al.
Pageof 115